SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence. - Alfonso Arvez MJ; Tan GSQ; Leung MTY; Ademi Z; Bell JS (Journal of diabetes research, 2025)